Trulieve Cannabis (TRLV) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $10.01, -2.82% vs the prior close of $10.30.
- Volume 913.70K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
TRLV dips 2.8% to $10.01. Closed at $10.01, -2.82% vs the prior close of $10.30. Day range $9.81β$10.45, opened at $10.28.
TRLV daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β TRLV dips 2.8% to $10.01
- Closed at $10.01, -2.82% vs the prior close of $10.30. Day range $9.81β$10.45, opened at $10.28.
- Volume was 913.70K shares, 0.5x its 50-day average of 1.88M β lighter than usual.
- Price is -8.7% vs its 50-day average ($10.97) and +14.9% vs its 200-day average ($8.71).
- 52-week range $4.62β$13.28; today's close sits at 62% of that range, 24.6% below the 52-week high.
Oct 15, 2026 β TRLV jumps 3.3% to $10.30
- Closed at $10.30, +3.31% vs the prior close of $9.97. Day range $9.79β$10.48, opened at $10.01.
- Volume was 1.42M shares, 0.8x its 50-day average of 1.87M.
- Price is -5.9% vs its 50-day average ($10.95) and +18.3% vs its 200-day average ($8.71).
- 52-week range $4.62β$13.28; today's close sits at 66% of that range, 22.4% below the 52-week high.
Oct 14, 2026 β TRLV dips 1.4% to $9.97, a 1-month low, 3 down days in a row
- Closed at $9.97, -1.38% vs the prior close of $10.11. Day range $9.90β$10.50, opened at $10.07.
- Volume was 1.73M shares, 0.9x its 50-day average of 1.85M.
- Price is -8.6% vs its 50-day average ($10.91) and +14.7% vs its 200-day average ($8.70).
- 52-week range $4.62β$13.28; today's close sits at 62% of that range, 24.9% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 β TRLV dips 2.7% to $10.11, a 1-month low
- Closed at $10.11, -2.69% vs the prior close of $10.39. Day range $10.06β$10.49, opened at $10.42.
- Volume was 897.00K shares, 0.5x its 50-day average of 1.84M β lighter than usual.
- Price is -7.1% vs its 50-day average ($10.89) and +16.4% vs its 200-day average ($8.68).
- 52-week range $4.62β$13.28; today's close sits at 63% of that range, 23.9% below the 52-week high.
Oct 12, 2026 β TRLV dips 2.6% to $10.39
- Closed at $10.39, -2.62% vs the prior close of $10.67. Day range $10.35β$10.87, opened at $10.69.
- Volume was 1.01M shares, 0.5x its 50-day average of 1.84M β lighter than usual.
- Price is -4.3% vs its 50-day average ($10.86) and +19.8% vs its 200-day average ($8.67).
- 52-week range $4.62β$13.28; today's close sits at 67% of that range, 21.8% below the 52-week high.
Oct 9, 2026 β TRLV rises 2.9% to $10.67
- Closed at $10.67, +2.89% vs the prior close of $10.37. Day range $10.11β$10.74, opened at $10.39.
- Volume was 1.18M shares, 0.6x its 50-day average of 1.84M.
- Price is -1.4% vs its 50-day average ($10.82) and +23.2% vs its 200-day average ($8.66).
- 52-week range $4.62β$13.28; today's close sits at 70% of that range, 19.7% below the 52-week high.
Oct 8, 2026 β TRLV slides 3.8% to $10.37, a 1-month low
- Closed at $10.37, -3.80% vs the prior close of $10.78. Day range $9.87β$10.84, opened at $10.78.
- Volume was 1.50M shares, 0.8x its 50-day average of 1.83M.
- Price is -3.8% vs its 50-day average ($10.78) and +19.9% vs its 200-day average ($8.65).
- 52-week range $4.62β$13.28; today's close sits at 66% of that range, 21.9% below the 52-week high.
Oct 7, 2026 β TRLV rises 1.2% to $10.78
- Closed at $10.78, +1.22% vs the prior close of $10.65. Day range $10.55β$10.92, opened at $10.70.
- Volume was 2.01M shares, 1.1x its 50-day average of 1.81M.
- Price is +0.4% vs its 50-day average ($10.73) and +24.8% vs its 200-day average ($8.64).
- 52-week range $4.62β$13.28; today's close sits at 71% of that range, 18.8% below the 52-week high.
Oct 6, 2026 β TRLV ends flat (+0.0%) to $10.65, 5 down days in a row
- Closed at $10.65, +0.00% vs the prior close of $10.65. Day range $10.42β$10.83, opened at $10.68.
- Volume was 1.16M shares, 0.6x its 50-day average of 1.80M.
- Price is -0.3% vs its 50-day average ($10.69) and +23.5% vs its 200-day average ($8.63).
- 52-week range $4.62β$13.28; today's close sits at 70% of that range, 19.8% below the 52-week high.
- That makes 5 straight losses.
Oct 5, 2026 β TRLV dips 0.7% to $10.65, a 1-month low, 4 down days in a row
- Closed at $10.65, -0.65% vs the prior close of $10.72. Day range $10.39β$10.81, opened at $10.70.
- Volume was 1.90M shares, 1.1x its 50-day average of 1.78M.
- Price is +0.1% vs its 50-day average ($10.64) and +23.4% vs its 200-day average ($8.63).
- 52-week range $4.62β$13.28; today's close sits at 70% of that range, 19.8% below the 52-week high.
- That makes 4 straight losses.
Oct 2, 2026 β TRLV dips 1.4% to $10.72, a 1-month low, 3 down days in a row
- Closed at $10.72, -1.38% vs the prior close of $10.87. Day range $10.40β$11.30, opened at $10.96.
- Volume was 2.27M shares, 1.3x its 50-day average of 1.75M.
- Price is +1.2% vs its 50-day average ($10.59) and +24.2% vs its 200-day average ($8.63).
- 52-week range $4.62β$13.28; today's close sits at 70% of that range, 19.3% below the 52-week high.
- That makes 3 straight losses.
TRLV latest news & SEC filings
Every SEC filing by or about TRLV in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 24, 2026 Β· Form S-8 POS β S-8 POS filing
S-8 POS filing
Aug 24, 2026 Β· Form POSASR β POSASR filing
POSASR filing
Aug 11, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 1.01 β Signed a material agreement.
- Item 3.02 β Sold unregistered shares.
- Item 3.03 β Change to shareholder rights.
- Item 5.03 β Amended its charter or bylaws / changed fiscal year.
Aug 7, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $270.95M (prior year $302.09M) (-10.3% vs Jun 30, 2025)
Aug 7, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.01 β Completed an acquisition or sale of assets.
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Aug 5, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.07 β Reported shareholder vote results.
Jul 8, 2026 Β· Form SCHEDULE 13G β Passive stake (13G)
Passive stake (13G) β an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 2, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
Jun 26, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Rivers Kim A. sold 136,811 shares at $8.76 (β$1.20M) on Jun 26, 2026
- Rivers Kim A. sold 136,811 shares at $8.76 (β$1.20M) on Jun 26, 2026
- Rivers Kim A. sold 136,811 shares at $8.76 (β$1.20M) on Jun 26, 2026
- Rivers Kim A. sold 136,811 shares at $8.76 (β$1.20M) on Jun 26, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jun 25, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Rivers Kim A. sold 300,000 shares at $8.17 (β$2.45M) on Jun 25, 2026
- Rivers Kim A. sold 300,000 shares at $8.17 (β$2.45M) on Jun 25, 2026
- Rivers Kim A. sold 300,000 shares at $8.17 (β$2.45M) on Jun 25, 2026
- Rivers Kim A. sold 300,000 shares at $8.17 (β$2.45M) on Jun 25, 2026
- Rivers Kim A. sold 400,000 shares at $8.17 (β$3.27M) on Jun 24, 2026
- Rivers Kim A. sold 400,000 shares at $8.17 (β$3.27M) on Jun 24, 2026
- β¦plus 6 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jun 25, 2026 Β· Form DEF 14A β Proxy statement
Proxy statement β agenda for the shareholder meeting (board elections, executive pay, votes)
Jun 25, 2026 Β· Form DEFA14A β Additional proxy materials
Additional proxy materials
Jun 22, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Rivers Kim A. sold 204,815 shares at $9.35 (β$1.92M) on Jun 22, 2026
- Rivers Kim A. sold 204,815 shares at $9.35 (β$1.92M) on Jun 22, 2026
- Rivers Kim A. sold 204,815 shares at $9.35 (β$1.92M) on Jun 22, 2026
- Rivers Kim A. sold 204,815 shares at $9.35 (β$1.92M) on Jun 22, 2026
- Rivers Kim A. sold 139,846 shares at $9.46 (β$1.32M) on Jun 18, 2026
- Rivers Kim A. sold 139,846 shares at $9.46 (β$1.32M) on Jun 18, 2026
- β¦plus 3 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Things to know before you trade TRLV
- Last results release: May 7, 2026 (8-K Item 2.02). Previous ones: Feb 26, 2026, Nov 5, 2025, Aug 6, 2025. Based on that rhythm, the next report is likely around Aug 6, 2026 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.62% (largest 12.2%).
- Liquidity: about 2.03M shares (β$20.36M) trade per day on average.
- 52-week position: $10.01 vs a range of $4.62β$13.28 (62% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Kim A. Rivers sold 136,811 shares on Jun 26, 2026.
- Latest filings: 8-K Aug 11, 2026; 10-Q Aug 7, 2026; 8-K Aug 7, 2026.
- Listing: NYSE Β· industry: Medicinal Chemicals & Botanical Products.
TRLV market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 10.28 | 10.45 | 9.81 | 10.01 | 913.70K |
| Oct 15, 2026 | 10.01 | 10.48 | 9.79 | 10.30 | 1.42M |
| Oct 14, 2026 | 10.07 | 10.50 | 9.90 | 9.97 | 1.73M |
| Oct 13, 2026 | 10.42 | 10.49 | 10.06 | 10.11 | 897.00K |
| Oct 12, 2026 | 10.69 | 10.87 | 10.35 | 10.39 | 1.01M |
| Oct 9, 2026 | 10.39 | 10.74 | 10.11 | 10.67 | 1.18M |
| Oct 8, 2026 | 10.78 | 10.84 | 9.87 | 10.37 | 1.50M |
| Oct 7, 2026 | 10.70 | 10.92 | 10.55 | 10.78 | 2.01M |
| Oct 6, 2026 | 10.68 | 10.83 | 10.42 | 10.65 | 1.16M |
| Oct 5, 2026 | 10.70 | 10.81 | 10.39 | 10.65 | 1.90M |
| Oct 2, 2026 | 10.96 | 11.30 | 10.40 | 10.72 | 2.27M |
| Oct 1, 2026 | 10.87 | 11.28 | 10.70 | 10.87 | 2.55M |
| Sep 30, 2026 | 10.86 | 11.17 | 10.22 | 10.90 | 8.37M |
| Sep 29, 2026 | 12.29 | 12.54 | 12.22 | 12.41 | 1.72M |
| Sep 28, 2026 | 12.09 | 12.88 | 11.88 | 12.34 | 1.49M |
| Sep 25, 2026 | 12.25 | 12.49 | 12.11 | 12.21 | 1.01M |
| Sep 24, 2026 | 12.41 | 12.57 | 11.94 | 12.27 | 1.73M |
| Sep 23, 2026 | 12.40 | 12.93 | 12.26 | 12.54 | 2.99M |
| Sep 22, 2026 | 11.50 | 12.47 | 11.43 | 12.47 | 3.25M |
| Sep 21, 2026 | 11.19 | 11.80 | 10.85 | 11.50 | 1.58M |
About Trulieve Cannabis
Trulieve Cannabis (TRLV) is listed on the NYSE and classified by the SEC under βMedicinal Chemicals & Botanical Productsβ. Its business address is in TALLAHASSEE, FL. State of incorporation: British Columbia, Canada. Fiscal year ends December 31. SEC CIK 1754195.
TRLV board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Thad Beshears | Director | Mar 17, 2026 |
| Matthew J. Foulston | Director | Mar 17, 2026 |
| Peter Healy | Director | Mar 17, 2026 |
| Thomas L Millner | Director | Mar 17, 2026 |
| Richard S. May | Director | Mar 17, 2026 |
| Jane Cecil Morreau | Director | Mar 17, 2026 |
| Kim A. Rivers | Chairman and CEO | Jun 26, 2026 |
| Susan Thronson | Director | Mar 17, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Christine Ann Hersey | Chief Corp Affairs & Strategy | Mar 17, 2026 |
| Nilyum Jhala | Chief Technology Officer | Mar 17, 2026 |
| Kyle Landrum | Chief Production Officer | Mar 17, 2026 |
| Joy Malivuk | Chief Accounting Officer | Dec 8, 2025 |
| Timothy Morey | Chief Sales Officer | Dec 8, 2025 |
| Jason Pernell | President | Mar 17, 2026 |
| Eric Powers | Chief Legal Officer | Mar 17, 2026 |
| Jan Reese | Chief Financial Officer | Mar 17, 2026 |
| Kim A. Rivers | Chairman and CEO | Jun 26, 2026 |
| Brett R. Walsh | Chief Accounting Officer | Mar 17, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 26, 2026 | Kim A. Rivers | Sale | 136,811 | $8.76 |
| Jun 26, 2026 | Kim A. Rivers | Sale | 136,811 | $8.76 |
| Jun 26, 2026 | Kim A. Rivers | Sale | 136,811 | $8.76 |
| Jun 26, 2026 | Kim A. Rivers | Sale | 136,811 | $8.76 |
| Jun 25, 2026 | Kim A. Rivers | Sale | 300,000 | $8.17 |
| Jun 25, 2026 | Kim A. Rivers | Sale | 300,000 | $8.17 |
| Jun 25, 2026 | Kim A. Rivers | Sale | 300,000 | $8.17 |
| Jun 25, 2026 | Kim A. Rivers | Sale | 300,000 | $8.17 |
| Jun 24, 2026 | Kim A. Rivers | Sale | 400,000 | $8.17 |
| Jun 24, 2026 | Kim A. Rivers | Sale | 400,000 | $8.17 |
| Jun 24, 2026 | Kim A. Rivers | Sale | 400,000 | $8.17 |
| Jun 24, 2026 | Kim A. Rivers | Sale | 400,000 | $8.17 |
| Jun 23, 2026 | Kim A. Rivers | Sale | 380,000 | $8.47 |
| Jun 23, 2026 | Kim A. Rivers | Sale | 380,000 | $8.47 |
| Jun 23, 2026 | Kim A. Rivers | Sale | 380,000 | $8.47 |
TRLV financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.18B | β | -0.58 | $272.82M |
| Dec 31, 2024 | $1.19B | β | -0.79 | $271.48M |
| Dec 31, 2023 | $1.13B | β | -2.28 | $201.84M |
| Dec 31, 2022 | $1.22B | $-252.73M | -0.95 | $23.10M |
| Dec 31, 2021 | $931.93M | $17.45M | 0.21 | $12.90M |
Latest balance sheet: total assets $2.08B, total liabilities $1.31B, cash $325.42M (as of Jun 30, 2026).
TRLV earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| May 7, 2026 | 8-K Item 2.02 (results) | $9.31 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $6.50 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $6.77 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $5.28 |
| May 7, 2025 | 8-K Item 2.02 (results) | $4.36 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $4.36 |
| Nov 5, 2024 | 8-K Item 2.02 (results) | $11.65 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | β |
| May 9, 2024 | 8-K Item 2.02 (results) | β |
| Feb 29, 2024 | 8-K Item 2.02 (results) | β |
| Nov 9, 2023 | 8-K Item 2.02 (results) | β |
| Aug 9, 2023 | 8-K Item 2.02 (results) | β |
Related stocks Β· Medicinal Chemicals & Botanical Products
Definium Therapeutics (DFTX)Tilray Brands (TLRY)IM Cannabis (IMCC)Glass House Brands (GLAS)Aurora Cannabis (ACB)Cronos (CRON)Usana Health Sciences (USNA)Regencell Bioscience (RGC)Canopy Growth (CGC)Sndl (SNDL)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on TRLV
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.